We serve our patients with the highest quality of care and access to the most advanced treatments. We're caring for eye health today while working to discover tomorrow's cures of the leading causes of blindness.

AMD

Funds that support Age Related Macular Degeneration (AMD) Include:

W. Randall McLaughlin Honorary Faculty Support Fund
Fund number: 318718

Established November 24, 2025, the W. Randall McLaughlin Honorary Support Fund is used to support innovative macular degeneration and retinal disease research, strengthen patient care and translational research programs, and to create a lasting legacy of hope for those facing vision loss.

Make a Gift

 

John and Annie Glenn

John and Annie Glenn Fund for Eye Research
Fund number: 642551 

Established June 8, 2018, with a gift from L. Carol Laxson, MD, PhD (PhD 1982, MD 1985) and Thomas F. Mauger, OD, MD (MS 1981, OD 1981, MD 1984); used to support advancements in research in the Department of Ophthalmology & Visual Sciences for innovative cures for blindness and eye disease including macular degeneration and glaucoma.

Make a Gift

Funding Opportunities

Discover a variety of funding opportunities designed to support innovative research and advancements in critical areas of ophthalmology. These opportunities aim to drive progress in patient care and treatment, offering support for projects that promise to make a significant impact on vision health and beyond.

Research Booklet

Cover of 2025 Research Booklet: Impact Eye Innovations with a CLICK HERE buttonYour generosity fuels discovery. Impact Eye Innovations offers an in-depth look at the groundbreaking work happening across our department - from advancements in cornea, glaucoma, and retina research to the clinical trials bringing new treatments closer to patients. The booklet highlights the passion and expertise of our three physician-scientists and nine vision scientists, each dedicated to transforming the future of eye care through innovative science.